内容へ

口腔顎顔面外科

抗凝固療法の管理と中和

Risk of bleeding after dentoalveolar surgery in patients taking anticoagulants. (新しいタブで開く)

Broekema FI, van Minnen B, Jansma J, Bos RR.

出典‎: Br J Oral Maxillofac Surg 2014;52(3):e15-9.

インデックス‎: PubMed 24485810

DOI‎: 10.1016/j.bjoms.2014.01.006

https://www.ncbi.nlm.nih.gov/pubmed/24485810 (新しいタブで開く)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (新しいタブで開く)

Levi M, Eerenberg E, Kamphuisen PW.

出典‎: J Thromb Haemost 2011;9(9):1705-12.

インデックス‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (新しいタブで開く)

Emergency reversal of warfarin anticoagulation. (新しいタブで開く)

Lin Y, Callum J.

出典‎: CMAJ 2010;182(18):2004.

インデックス‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (新しいタブで開く)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (新しいタブで開く)

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.

出典‎: Thromb Haemost 2012;108(2):217-24.

インデックス‎: PubMed 22627883

DOI‎: 10.1160/TH12-03-0179

https://www.ncbi.nlm.nih.gov/pubmed/22627883 (新しいタブで開く)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (新しいタブで開く)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

出典‎: Anesth Analg 2011;113(4):703-10.

インデックス‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (新しいタブで開く)